AstraZeneca has proposed price cuts to its drugs in the United States, its CEO said on Tuesday, days after unveiling a $50 ...

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

The One Big Beautiful Bill Act ("OBBB") expands exemptions for orphan drugs from mandatory Medicare price negotiations and modifies their ...

The One Big Beautiful Bill Act takes a big step in the rare disease space by expanding the contours of the orphan drug ...

As the Trump administration begins to make its mark on the Medicare drug price negotiation program, litigation over the ...

Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...

The Alliance for Patient Access commissioned Apteka LLC to release a new issue brief highlighting the unintended consequences of Medicare negotiations, particularly related to Medicare Part B. This ...

Over the coming years, the Inflation Reduction Act aims to help those with Medicare save on their prescription drug costs. Learn more.

The Trump administration today announced steps drug manufacturers must take to lower prescription drug prices in the U.S. to "most favored nation" pricing, the lowest cost paid for the same ...

The pharmaceutical industry has a fresh sense of direction after President Donald Trump’s tax-and-spending law included a ...

Earlier this year, President Trump issued an executive order pledging “immediate steps to end global freeloading” and ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug price negotiations ...